Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Tips from these results
- Buy Woodbois Limited (WBI) by Tom Winnifrith in Hot Stock Rockets
- Buy Haynes Publishing Group (HYNS) by Edmond Jackson in Interactive Investor
- Buy Sage Group (SGE) by Edward Sheldon in The Motley Fool
- Buy SThree (STHR) by Alan Oscroft in The Motley Fool
- Buy Ashtead Group (AHT) by Alan Oscroft in The Motley Fool
- Buy Rightmove (RMV) by Edward Sheldon in The Motley Fool
- Sell Aggregated Micro Power Holdings (AMPH) by Steve Moore in ShareProphets
- Long Term Buy Rolls-Royce Holdings (RR.) by Manika Premsingh in The Motley Fool
- Avoid Xaar (XAR) by Steve Moore in ShareProphets
- Sell Diversified Gas & Oil (DGOC) by Tom Winnifrith in ShareProphets
- Avoid Aston Martin Lagonda Global Holdings (AML) by Kirsteen Mackay in The Motley Fool
- Buy Johnson Matthey (JMAT) by Kirsteen Mackay in The Motley Fool
- Long Term Buy Tesco (TSCO) by Roland Head in The Motley Fool
- Long Term Buy Admiral Group (ADM) by Rupert Hargreaves in The Motley Fool
- Buy BHP Group (BHP) by Rupert Hargreaves in The Motley Fool
- Buy Glencore (GLEN) by Rupert Hargreaves in The Motley Fool
- Buy Cineworld Group (CINE) by Peel Hunt
- Buy ITV (ITV) by Malcolm Stacey in ShareProphets
- Buy Compass Group (CPG) by Miles Costello in The Times
- Hold Lloyds Banking Group (LLOY) by Richard Evans in The Telegraph - Questor
AstraZeneca (AZN)
Health Care Sector
-
Latest quote
6,865.00p (mid)
-
Current Change (%)
-0.61%
-
Price
Bid: 6,861.00p
Offer: 6,862.00p
-
Today
High: 6,909.80p
Low: 6,803.00p
-
This year
High: 7,533.00p
Low: 5,325.00p
-
Information
Volume: 819,806
Market Cap: £90000.15M
AstraZeneca Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.AstraZeneca RNS Feed
NOTE: This is based on 278 open tips for this company
